Search clinical trials for: GFX

Total 376 results

Universidade Estadual de Londrina

Completed

Body Fat and Frequency of Resistance Training

Obesity
Advanced Cosmetic Intervention

Completed

A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

Glabellar Furrowing

United States, Canada
Advanced Cosmetic Intervention

Completed

A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing

Forehead Wrinkles | Glabellar Furrowing

United States
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
University of Thessaly

Recruiting

Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture (Gr-GFI)

Hip Fractures | Frailty Syndrome

Greece
Amicus Therapeutics

Active, not recruiting

Gene Therapy for Children With CLN3 Batten Disease

Batten Disease | CLN3

United States
Ultragenyx Pharmaceutical Inc

Active, not recruiting

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Angelman Syndrome

United States, United Kingdom, Canada, Australia, France, Germany, Spain, Israel
Akero Therapeutics, Inc

Active, not recruiting

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NASH - Nonalcoholic Steatohepatitis

United States, Mexico, Puerto Rico
Akero Therapeutics, Inc

Completed

A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NASH - Nonalcoholic Steatohepatitis

United States, Puerto Rico
Cierra

Suspended

PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)

Patent Foramen Ovale

France, Germany, Belgium
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

Sickle Cell Disease | Glomerular Disease | Renal Disease

United States
Gem Pharmaceuticals

Completed

GPX-100 in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Afexa Life Sciences Inc

Withdrawn

Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

United States
Akero Therapeutics, Inc

Active, not recruiting

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony)

NASH - Nonalcoholic Steatohepatitis

United States, Puerto Rico
Goldfinch Bio, Inc.

Terminated

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Kidney Diseases | Glomerulonephritis | Nephritis | Nephrosis | Glomerulosclerosis | Focal Segmental Nephrosis | Lipoid Urologic Disease

United States
GTx

Completed

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Prostate Cancer

United States
Association d' Utilisation du Rein Artificiel SANTE

Recruiting

Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease (EPSER)

Kidney Function Issue

France
Goldfinch Bio, Inc.

Completed

FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Healthy Volunteers

United States
Children's Hospital Medical Center, Cincinnati

Completed

Fuzzy AI Using VR for Collision Prevention (CAT)

Injuries

United States
Cierra

Completed

The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

Foramen Ovale, Patent

Germany
GTx

Withdrawn

Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

Elevated Triglycerides

Canada
GTx

Completed

GTx-024 as a Treatment for Stress Urinary Incontinence in Women

Stress Urinary Incontinence

United States
Cierra

Suspended

PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness (Paradigm IV)

Stroke | Migraine | Transient Ischemic Attack | Decompression Illness | PFO

Germany
Amicus Therapeutics

Active, not recruiting

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Batten Disease | CLN6

United States
Goldfinch Bio, Inc.

Terminated

A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Kidney Diseases | Urologic Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Complications | Diabetic Nephropathies | Glomerulonephritis | Nephritis | Glomerulosclerosis, Focal Segmental | Nephrosis | Nephrosis, Lipoid

United States
Taipei Medical University Hospital

Completed

Preoperative Renal Insufficiency Predicts Postoperative Adverse Outcomes

Renal Insufficiency | Morality

Taiwan
Manchester University NHS Foundation Trust
University of Manchester

Completed

BOne Dysfunction in Donor NEphrectomieS (BONES)

Renal Failure | Kidney Donors

United Kingdom
GTx

Completed

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Cachexia

United States, Canada
Cierra

Unknown

Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism

Patent Foramen Ovale

Germany
Harvard Medical School (HMS and HSDM)
National Institute of Allergy and Infectious Diseases (NIAID); Partners in... and other collaborators

Recruiting

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens (STEM-TB)

HIV | Tuberculosis, Multidrug-Resistant

Kazakhstan, Lesotho, Peru
Glycotope GmbH

Completed

PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer Recurrent

Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
Assiut University

Unknown

Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients

CKD | GIT - Gastrointestinal Tract Hemorrhage
RWTH Aachen University

Completed

Heart Cycle Prestudy (PreGEx)

Coronary Artery Disease | Acute Myocardial Infarction

Germany
Acessa Health, Inc.

Active, not recruiting

Post Market TRUST Study (TRUST)

Uterine Fibroids

Canada
Glycotope GmbH

Completed

PankoMab-GEX™: Phase 1 Dose Escalation Study

Solid Tumors

Germany, Italy, Switzerland
GTx

Completed

Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence (ASTRID)

Stress Urinary Incontinence

United States
Morphogenesis, Inc.

Completed

IFx-Hu2.0 for the Treatment of Patients With Skin Cancer

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
Pearl Therapeutics, Inc.

Completed

A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

COPD

Belgium
Corindus Inc.

Terminated

CorPath GRX STEMI Study (TREAT GRX)

CAD | STEMI - ST Elevation Myocardial Infarction

United States
NFlection Therapeutics, Inc.

Completed

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Neurofibromatosis 1 | Cutaneous Neurofibroma

United States
Amicus Therapeutics

Completed

Gene Therapy for Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease

Variant Late-Infantile Neuronal Ceroid Lipofuscinosis

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

Head and Neck Neoplasms

United States, Australia, Austria, Belgium, Brazil, Canada, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Taiwan, Turkey, United Kingdom
GTx

Completed

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Non-Small Cell Lung Cancer | Muscle Wasting

United States
SC Medica

Not yet recruiting

Effectiveness and Safety of the Facet Fixation (FFX®) Implant in the Treatment of Degenerative Lumbar Spinal Stenosis (FFX® RCT)

Degenerative Lumbar Spinal Stenosis
GTx

Withdrawn

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Pearl Therapeutics, Inc.

Completed

Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD

COPD

United States
Corindus Inc.

Terminated

NAVIGATE GRX Study

Coronary Artery Disease

Poland
Vienna Institute for Research in Ocular Surgery

Recruiting

Performance of Two Hydrophobic IOLs

Cataract

Austria
GTx

Terminated

GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer

Prostate Cancer

United States

Search clinical trials for: GFX

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations